Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1968 1
1969 3
1970 2
1971 1
1974 1
1985 1
1986 1
1988 1
1992 1
1994 1
1995 1
1998 1
2000 1
2003 1
2005 2
2007 1
2008 2
2009 5
2010 3
2011 3
2012 5
2013 5
2014 7
2015 18
2016 29
2017 20
2018 19
2019 21
2020 6
2021 11
2022 11
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Results by year

Filters applied: . Clear all
Page 1
Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumors.
Zhang H, Yu P, Tomar VS, Chen X, Atherton MJ, Lu Z, Zhang HG, Li S, Ortiz A, Gui J, Leu NA, Yan F, Blanco A, Meyer-Ficca ML, Meyer RG, Beiting DP, Li J, Nunez-Cruz S, O'Connor RS, Johnson LR, Minn AJ, George SS, Koumenis C, Diehl JA, Milone MC, Zheng H, Fuchs SY. Zhang H, et al. Among authors: tomar vs. Nat Cancer. 2022 Jul;3(7):808-820. doi: 10.1038/s43018-022-00383-0. Epub 2022 May 30. Nat Cancer. 2022. PMID: 35637402 Free PMC article.
Protection of Regulatory T Cells from Fragility and Inactivation in the Tumor Microenvironment.
Zhang H, Tomar VS, Li J, Basavaraja R, Yan F, Gui J, McBrearty N, Costich TL, Beiting DP, Blanco MA, Conejo-Garcia JR, Saggu G, Berger A, Nefedova Y, Gabrilovich DI, Fuchs SY. Zhang H, et al. Among authors: tomar vs. Cancer Immunol Res. 2022 Dec 2;10(12):1490-1505. doi: 10.1158/2326-6066.CIR-22-0295. Cancer Immunol Res. 2022. PMID: 36255418 Free PMC article.
Role of gold and silver nanoparticles in cancer nano-medicine.
Chugh H, Sood D, Chandra I, Tomar V, Dhawan G, Chandra R. Chugh H, et al. Among authors: tomar v. Artif Cells Nanomed Biotechnol. 2018;46(sup1):1210-1220. doi: 10.1080/21691401.2018.1449118. Epub 2018 Mar 13. Artif Cells Nanomed Biotechnol. 2018. PMID: 29533101 Review.
Priorities for cancer research in low- and middle-income countries: a global perspective.
Pramesh CS, Badwe RA, Bhoo-Pathy N, Booth CM, Chinnaswamy G, Dare AJ, de Andrade VP, Hunter DJ, Gopal S, Gospodarowicz M, Gunasekera S, Ilbawi A, Kapambwe S, Kingham P, Kutluk T, Lamichhane N, Mutebi M, Orem J, Parham G, Ranganathan P, Sengar M, Sullivan R, Swaminathan S, Tannock IF, Tomar V, Vanderpuye V, Varghese C, Weiderpass E. Pramesh CS, et al. Among authors: tomar v. Nat Med. 2022 Apr;28(4):649-657. doi: 10.1038/s41591-022-01738-x. Epub 2022 Apr 19. Nat Med. 2022. PMID: 35440716 Free PMC article. Review.
182 results